Literature DB >> 10708451

Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie.

N A Mabbott1, A Williams, C F Farquhar, M Pasparakis, G Kollias, M E Bruce.   

Abstract

In most peripheral infections of rodents and sheep with scrapie, infectivity is found first in lymphoid tissues and later in the central nervous system (CNS). Cells within the germinal centers (GCs) of the spleen and lymph nodes are important sites of extraneural replication, from which infection is likely to spread to the CNS along peripheral nerves. Here, using immunodeficient mice, we investigate the identity of the cells in the spleen that are important for disease propagation. Despite possessing functional T and B lymphocytes, tumor necrosis factor alpha-deficient (TNF-alpha(-/-)) mice lack GCs and follicular dendritic cell (FDC) networks in lymphoid tissues. In contrast, lymphoid tissues of interleukin-6-deficient (IL-6(-/-)) mice possess FDC networks but have impaired GCs. When the CNSs of TNF-alpha(-/-), IL-6(-/-), and wild-type mice were directly challenged with the ME7 scrapie strain, 100% of the mice were susceptible, developing disease after closely similar incubation periods. However, when challenged peripherally (intraperitoneally), most TNF-alpha(-/-) mice failed to develop scrapie up to 503 days postinjection. All wild-type and IL-6(-/-) mice succumbed to disease approximately 300 days after the peripheral challenge. High levels of scrapie infection and the disease-specific isomer of the prion protein, PrP(Sc), were detectable in spleens from challenged wild-type and IL-6(-/-) mice but not from TNF-alpha(-/-) mice. Histopathological analysis of spleen tissue demonstrated heavy PrP accumulations in direct association with FDCs in challenged wild-type and IL-6(-/-) mice. No PrP(Sc) accumulation was detected in spleens from TNF-alpha(-/-) mice. We conclude that, for the ME7 scrapie strain, mature FDCs are critical for replication in lymphoid tissues and that in their absence, neuroinvasion following peripheral challenge is impaired.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708451      PMCID: PMC111835          DOI: 10.1128/jvi.74.7.3338-3344.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations.

Authors:  A Williams; A M Van Dam; D Ritchie; P Eikelenboom; H Fraser
Journal:  Brain Res       Date:  1997-04-18       Impact factor: 3.252

Review 2.  TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview.

Authors:  W E Klinkert; K Kojima; W Lesslauer; W Rinner; H Lassmann; H Wekerle
Journal:  J Neuroimmunol       Date:  1997-02       Impact factor: 3.478

Review 3.  TNF-alpha transgenic and knockout models of CNS inflammation and degeneration.

Authors:  L Probert; K Akassoglou; G Kassiotis; M Pasparakis; L Alexopoulou; G Kollias
Journal:  J Neuroimmunol       Date:  1997-02       Impact factor: 3.478

4.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.

Authors:  A F Hill; M Zeidler; J Ironside; J Collinge
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

Review 5.  To 'B' or not to 'B' a germinal center?

Authors:  M H Kosco-Vilbois; H Zentgraf; J Gerdes; J Y Bonnefoy
Journal:  Immunol Today       Date:  1997-05

6.  A crucial role for B cells in neuroinvasive scrapie.

Authors:  M A Klein; R Frigg; E Flechsig; A J Raeber; U Kalinke; H Bluethmann; F Bootz; M Suter; R M Zinkernagel; A Aguzzi
Journal:  Nature       Date:  1997 Dec 18-25       Impact factor: 49.962

7.  PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain.

Authors:  T Blättler; S Brandner; A J Raeber; M A Klein; T Voigtländer; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

8.  Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice.

Authors:  D M Taylor; I McConnell; H Fraser
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

9.  Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent.

Authors:  M E Bruce; R G Will; J W Ironside; I McConnell; D Drummond; A Suttie; L McCardle; A Chree; J Hope; C Birkett; S Cousens; H Fraser; C J Bostock
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

10.  Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice.

Authors:  R Kordek; V R Nerurkar; P P Liberski; S Isaacson; R Yanagihara; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  47 in total

Review 1.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

Review 2.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

3.  Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells.

Authors:  P S Kaeser; M A Klein; P Schwarz; A Aguzzi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Interaction between dendritic cells and nerve fibres in lymphoid organs after oral scrapie exposure.

Authors:  Gauthier Dorban; Valérie Defaweux; Caroline Demonceau; Sylvain Flandroy; Pierre-Bernard Van Lerberghe; Nandini Falisse-Poirrier; Joëlle Piret; Ernst Heinen; Nadine Antoine
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

5.  Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro.

Authors:  Katarina M Luhr; Robert P A Wallin; Hans-Gustaf Ljunggren; Peter Löw; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 6.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

7.  Neuroinvasion in prion diseases: the roles of ascending neural infection and blood dissemination.

Authors:  Sílvia Sisó; Lorenzo González; Martin Jeffrey
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-23

8.  Role of interleukin-1 in prion disease-associated astrocyte activation.

Authors:  Julia Schultz; Anja Schwarz; Sabine Neidhold; Michael Burwinkel; Constanze Riemer; Dietrich Simon; Manfred Kopf; Markus Otto; Michael Baier
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  Prions and lymphoid organs: solved and remaining mysteries.

Authors:  Tracy O'Connor; Adriano Aguzzi
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.